Anne Sundberg's 200,000 school ban doc shocks Oscar circuit in 2027

# Anne Sundberg's Smartphone Documentary Aims to Shock Oscar Circuit In a bold move that signals a growing awareness of digital wellness, independent distributor Obscured Releasing has secured North American rights to *The Drug in Our Pocket*, a hard‑hitting documentary that lays bare how smartphones have reshaped the lives of today’s youth.

Directed by Anne Sundberg and produced alongside Beth Kojima, the feature will debut this Saturday at the Hamptons International Film Festival, then roll through the Heartland International Film Festival in Indianapolis and the Newport Beach Film Festival in Southern California.

With an Oscar‑qualifying run slated for fall, the film is poised for a limited theatrical release in early 2027, positioning it at the forefront of the year's most talked‑about documentaries. *The Drug in Our Pocket* takes a sweeping look at the technology that has become a constant in every pocket across America.

The film argues that smartphones, conceived as tools for connection, have inadvertently become a toxic catalyst for anxiety, distraction, and identity crises among teens and young adults.

By weaving intimate conversations with students, parents, and leading psychologists, it paints a stark picture of a generation grappling with the relentless pull of notifications.

The documentary’s timing could not be more relevant: in the last three years, over 200 000 schools nationwide have either banned or strictly limited phone use during class hours, while several countries—Australia, France, Greece, Malaysia, and Brazil—have enacted sweeping restrictions on social‑media access for minors.

The project draws on a robust team of seasoned filmmakers. Anne Sundberg, whose past collaborations with Ricki Stern include *The Trials of Darryl Hunt* and *Reversing Roe*, brings a deep narrative sensibility to the film.

Producers Beth Kojima and Sundberg co‑wrote the script with John Wayland, who also edited the final cut. The score, crafted by Timo Elliston and Brian Jones, underpins the film’s emotional arc.

Executive producers—among them Jenna Bush Hager, Crystal McCrary McGuire, Ashley Graham, and the Tisch family—highlight the documentary’s broad appeal and the confidence that industry veterans have in its message. ### Background & Context The partnership between Sundberg’s creative team and Obscured Releasing marks a deliberate strategy to align the film’s potent narrative with a distribution model that favors festival buzz, critical attention, and targeted releases.

Founded in 2025 by RJ Millard and Bill Guentzler, Obscured Releasing has already carved a niche for itself with a slate that balances indie dramas and documentaries.

Their recent titles, such as the theatrical drama *Blue Film* and the documentary *Stop The Insanity: Finding Susan Powter*, demonstrate a knack for marrying strong storytelling with thoughtful release plans that maximize audience reach.

What sets *The Drug in Our Pocket* apart is its focus on a societal issue that has reached the fingertips of millions. The film delves into how the design of modern smartphones and social media platforms taps into deep psychological mechanisms, turning screens into addictive vessels that demand constant attention.

By featuring candid interviews with tech whistleblowers, the documentary exposes how big tech has often prioritized engagement metrics over user wellbeing, while government bodies have struggled to keep pace with the rapid evolution of digital life. the film is grounded in the lived experiences of its subjects.

Teens across the country share stories of sleepless nights, social anxiety, and the relentless pressure to curate a flawless online persona. Parents, too, recount moments of watching their children vanish into glowing screens, grappling with the tension between fostering independence and protecting mental health.

By combining these personal narratives with expert analysis, the film offers a multifaceted view that resonates with both policymakers and everyday viewers. ### What People Are Saying Industry insiders view the acquisition as a watershed moment for socially conscious cinema.

RJ Millard and Bill Guentzler expressed excitement about the film’s potential, noting that “*The Drug in Our Pocket* brilliantly weaves psychological expert interviews, behind‑the‑scenes stories from tech whistleblowers, and deeply personal accounts of teenagers and parents exposing how big tech and our government have failed us.” Their enthusiasm underscores a shared belief that the documentary could ignite a broader conversation about digital wellness and regulatory oversight.

Early festival screenings have already sparked discussion among critics and audiences alike. At the Hamptons International Film Festival, attendees left the theater buzzing about the stark parallels between the film’s revelations and the current wave of policy proposals aimed at curbing smartphone usage in schools.

Reviewers praised the film’s balanced approach, noting that it neither demonizes technology nor absolves tech giants of responsibility. Instead, it offers a sobering look at the unintended consequences of a culture that prizes constant connectivity.

Social media responses have been equally intense. While some users applaud the film for shedding light on a pervasive issue, others criticize what they perceive as an alarmist tone.

Nevertheless, the debate has amplified the documentary’s reach, with many educators, mental‑health professionals, and tech ethicists . ### What Happens Next Obscured Releasing’s rollout plan is carefully calibrated to build momentum leading into the award season.

After the film’s festival circuit, it will enter a short, Oscar‑qualifying run in selected New York and Los Angeles theaters—a strategy designed to meet Academy eligibility while sustaining buzz.

This will be followed by a limited theatrical release in early 2027, complemented by a strategic VOD window that allows viewers worldwide to engage with the content long after the festival lights dim.

The distribution strategy reflects a broader trend among independent distributors to leverage festivals as springboards for critical acclaim and award recognition.

By positioning the film within a curated selection of high‑profile festivals, Obscured Releasing hopes to attract both critics and industry insiders who can amplify its message through word‑of‑mouth and media coverage.

Beyond this project, Obscured Releasing is set to expand its slate with titles that span genres and formats, from narrative dramas like *She’s the He* to socially relevant documentaries such as *Endless Cookie*.

The company’s founders emphasize a commitment to “film‑first” distribution, prioritizing collaborative partnerships that engage audiences through a mix of theatrical runs, festival play, and carefully timed VOD releases.

As the documentary’s release approaches, the call to action remains clear: viewers are invited to reflect on their own smartphone habits, engage in conversations about digital wellness, and advocate for policies that protect young people from the darker side of constant connectivity.

Whether it sparks legislative change or simply prompts a personal reevaluation, *The Drug in Our Pocket* is poised to leave a lasting imprint on both the film world and the broader cultural conversation about technology and mental health.

In the coming months, the film will continue to ignite dialogue, challenge assumptions, and, perhaps, influence the next generation of policy and technology design—one screen at a time.